Inspira Technologies Oxy B.H.N. Ltd. (IINN)
- Previous Close
1.2550 - Open
1.2227 - Bid 1.1800 x 100
- Ask 1.2900 x 100
- Day's Range
1.1806 - 1.2500 - 52 Week Range
0.7610 - 2.4900 - Volume
21,310 - Avg. Volume
101,714 - Market Cap (intraday)
22.574M - Beta (5Y Monthly) 2.05
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
inspira-technologies.comRecent News: IINN
View MorePerformance Overview: IINN
Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IINN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IINN
View MoreValuation Measures
Market Cap
22.94M
Enterprise Value
20.15M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
4.29
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-59.53%
Return on Equity (ttm)
-116.54%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-11.29M
Diluted EPS (ttm)
-0.7800
Balance Sheet and Cash Flow
Total Cash (mrq)
7.36M
Total Debt/Equity (mrq)
15.30%
Levered Free Cash Flow (ttm)
-4.74M